learndrugs
Nervous

Parkinson’s Disease

PD Verified · Sep 2026

Parkinson’s disease (PD) is a progressive neurodegenerative movement disorder in which dopamine-producing neurons in the substantia nigra degenerate and alpha-synuclein accumulates in Lewy bodies, producing bradykinesia, resting tremor, rigidity, and later postural instability.

The disorder behind the pill-rolling tremor, the masklike face, the festinating gait, the on-time-every-time levodopa rule, the metoclopramide trap, and the withdrawal emergency that mimics neuroleptic malignant syndrome — and the reason aspiration pneumonia, not the tremor, is what kills.

What’s going wrong in the body

The normal physiology, where it fails, and why the body’s compensation backfires.

01 The substantia nigra runs out of dopamine

PD affects roughly 1% of people over 60 and 2–3% over 65, strikes men about twice as often as women, and is the fastest-growing neurodegenerative disorder worldwide. Its engine is the death of dopaminergic neurons in the substantia nigra pars compacta (SNpc) — cells that appear dark because of their neuromelanin, which is why the diseased nigra looks depigmented at autopsy. These neurons project to the striatum (putamen and caudate) along the nigrostriatal pathway; as they die, striatal dopamine falls and the basal-ganglia motor loops that select and scale movement lose their main modulator. By the time PD is diagnosed, more than 50% and up to 80% of these neurons have already degenerated.

The basal ganglia work through two opposing pathways that dopamine normally balances. The direct pathway (D1-receptor neurons) sends an inhibitory projection to the globus pallidus internus (GPi) and facilitates movement; the indirect pathway (D2-receptor neurons) runs through the globus pallidus externus and subthalamic nucleus, indirectly stimulates the GPi, and suppresses unwanted movement. Lose dopamine and both pathways tilt the same way: less D1 facilitation plus more D2-pathway drive means GPi overactivity, more inhibition of the thalamus, less excitatory input to the motor cortex — and the patient becomes slow and stiff. That circuit is the mechanism of bradykinesia and rigidity.

Dopamine does not act alone in the striatum. Its loss unbalances it against the excitatory neurotransmitter acetylcholine, and that dopamine–acetylcholine imbalance is the second half of every drug rationale on this page: dopaminergic drugs push one side up, anticholinergics pull the other side down.

Nigrostriatal dopamine loss tilts both basal-ganglia pathways toward GPi overactivity and thalamic inhibition, and leaves striatal acetylcholine relatively unopposed.

02 Why the drugs work — and why they stop working

Dopamine itself cannot cross the blood–brain barrier, but its precursor levodopa can. Surviving nigral neurons take it up, convert it to dopamine, and store it — which is why early PD has long, smooth "on" time: the remaining neurons act as a dopamine reservoir that buffers each oral dose. Carbidopa rides along to block peripheral dopa-decarboxylase, so less levodopa is converted to dopamine outside the brain; that lets more reach the CNS, cuts the levodopa dose needed by up to 75%, and blunts the nausea, vomiting, and diarrhea that peripheral dopamine causes.

As neurons keep dying the reservoir shrinks, and the brain becomes dependent on the moment-to-moment plasma level of a drug that lasts only about 3 to 4 hours. "On" time shortens, wearing-off appears before the next dose, and swings between mobile "on" periods and immobile "off" periods become the daily rhythm; after 5 to 10 years of levodopa, about half of patients have these motor fluctuations. The other face of the same problem is dyskinesia — involuntary writhing of the mouth, tongue, face, neck, and limbs from long-term levodopa, worse the younger the patient was at onset. This is why timing is physiology, not paperwork: a late dose in a patient without a reservoir is an off state waiting to happen.

The rest of the armamentarium works around this bottleneck. Dopamine agonists stimulate receptors directly without needing surviving neurons; MAO-B inhibitors block dopamine breakdown in the striatum; COMT inhibitors extend each levodopa dose; amantadine boosts dopamine release and blocks reuptake; and anticholinergics attack the other side of the imbalance. Each brings its own hazards — impulse-control disorders and sleep attacks, serotonin syndrome, hallucinations, confusion — that the nursing layer below is built to catch.

03 Alpha-synuclein, Lewy bodies, and the Braak climb

PD is a synucleinopathy. Alpha-synuclein is a 140-amino-acid presynaptic protein that normally helps assemble the SNARE complex and traffic vesicles; when it misfolds and aggregates it becomes toxic, neurons dysfunction and die, and the aggregates collect as Lewy bodies and Lewy neurites — the post-mortem finding that still makes the only definitive diagnosis. Lysosomal, endosomal, and mitochondrial dysfunction, plus immune and inflammatory signals that appear to originate in the gut, feed the process.

Braak staging describes the pathology climbing the nervous system: it starts in the myenteric plexus of the gut (stage 1), reaches the dorsal motor nucleus of the vagus and the olfactory nucleus (stage 2), then the locus ceruleus and substantia nigra (stage 3), then the basal forebrain, amygdala, and medial temporal structures (stage 4), and finally the neocortex (stage 5). That order explains the clinical timeline: constipation, loss of smell, autonomic dysfunction, and REM sleep behavior disorder precede motor signs, often by a decade or more — constipation has been documented up to 24 years before motor onset, and hyposmia affects 70–90% of patients — while dementia arrives late, once the cortex is involved. Pathological change may begin 10–15 years before anyone notices a tremor.

Braak staging: alpha-synuclein pathology ascends from the gut and brainstem to the substantia nigra and finally the cortex — so non-motor symptoms come first and dementia last.

04 Parkinsonism is not always Parkinson’s — and why the hospital MAR matters

Parkinsonism is the syndrome — rigidity, tremor, bradykinesia, unstable posture — and idiopathic PD accounts for about 80% of it. The rest is secondary (drug-induced, vascular, toxic, structural) or atypical "Parkinson-plus" disease (multiple system atrophy, progressive supranuclear palsy, corticobasal degeneration, dementia with Lewy bodies). The version nurses cause is drug-induced parkinsonism: dopamine D2 antagonists block striatal receptors and reproduce the whole motor syndrome with no neuron loss at all, which is why a DaTscan is symmetric and normal in that patient and why exposure to a dopamine antagonist is an absolute exclusion in the MDS diagnostic criteria. The culprits are ordinary hospital drugs: typical antipsychotics (haloperidol, fluphenazine), several atypicals (risperidone, ziprasidone, olanzapine), and the antiemetics metoclopramide, prochlorperazine, and droperidol. In a patient who already has PD, the same drugs blunt levodopa’s effect and precipitate abrupt motor worsening.

The mirror-image hazard is taking the dopamine away. Abrupt withdrawal or dose reduction of levodopa — or of amantadine — or a dose that is vomited or cannot be absorbed, can precipitate parkinsonism-hyperpyrexia syndrome, a neuroleptic-malignant-like emergency: mental status change, fever, muscle rigidity, and autonomic instability developing over 1–3 days, with a creatine kinase that can be profound and a white count of 10,000–40,000 with a left shift. "Abrupt withdrawal or dose reduction of levodopa is associated with an increased risk of neuroleptic malignant syndrome," and people with PD "should never stop taking carbidopa-levodopa without talking with a doctor." Treatment is to restart the dopaminergic drug, cool aggressively, correct volume, and support in the ICU; mortality is now under 10% — when it is recognized.

The hospital cascade: a late dose or a D2-blocking antiemetic produces an off state; the off state produces dysphagia and falls; sustained withdrawal produces the hyperpyrexia emergency.

Causes & risk factors

Modifiable factors are teaching targets — the patient can act on them.

Age — about 1% of people over 60 and 2–3% over 65; onset usually around 60 Male sex (≈ 2:1) Family history — ≈ 10% genetic; LRRK2 is the most common variant (40% of familial cases); also GBA1, SNCA, VPS35, PRKN, PINK1, DJ1 Onset before age 50, or two first-degree relatives (or one first-degree + one second-degree) with PD → genetic testing considered (DGN 2023) Pesticide and herbicide exposure; living near industrial plants modifiable Toxins — MPTP, manganese, carbon monoxide modifiable Mild to moderate head injury Dopamine-blocking drugs — antipsychotics, metoclopramide, prochlorperazine (drug-induced parkinsonism, reversible on withdrawal) modifiable Atherosclerosis (vascular parkinsonism) and viral infections Prodromal markers — REM sleep behavior disorder, loss of smell, constipation, daytime somnolence, orthostatic symptoms, erectile/urinary dysfunction, depression Physical inactivity — regular physical activity is associated with lower risk (the one protective association worth teaching; smoking and caffeine are also inversely associated but are not recommendations) modifiable Sleep, diet, and stress — healthy lifestyle linked to better outcomes and lower mortality once disease exists modifiable

Signs & symptoms

Each finding tied to the mechanism that produces it — and the triage it calls for.

Bradykinesia — slow initiation of movement with shrinking speed and amplitude on repetition early Expected
Why: GPi overactivity inhibits the thalamus and under-drives the motor cortex. Seen as slow finger and foot tapping, slow walking, and trouble rising from a chair. It is the core feature and is required for the diagnosis under MDS 2015 criteria.
Resting tremor — 4–6 Hz, "pill-rolling," typically unilateral at onset early Expected
Why: Loss of dopaminergic modulation lets oscillatory basal-ganglia-thalamic circuits run unchecked. Present when the limb is still, most obvious at rest or under stress, less responsive to treatment than bradykinesia — and the most common reason people first seek care. Asymmetry is the hallmark early: one side first, bilateral over years — a bilateral symmetric onset is a red flag for atypical parkinsonism.
Rigidity — lead-pipe or cogwheel resistance to passive movement, often asymmetric early Expected
Why: The same under-modulated motor circuit raises resting muscle tone; cogwheeling is rigidity with the tremor superimposed. Patients describe muscles that "stay tense and tight, causing achiness or stiffness." As nigral loss spreads to both hemispheres the features become bilateral, with postural instability, functional impairment, and loss of independence.
Masked facies, infrequent blinking, hypophonia (soft voice), micrographia (tiny handwriting) Expected
Why: Bradykinesia applied to the face, larynx, and hand: fewer, smaller, slower movements produce a mask-like expression, a voice that fades, and script that shrinks across the line. Masked face and soft voice impair communication and can be misread as depression or indifference.
Shuffling, festinating gait — short rapid steps hurrying forward, reduced arm swing, stooped flexed posture, turning en bloc Expected
Why: Automatic gait programs lose dopaminergic drive; the center of mass drifts ahead of the feet and the patient chases it. Freezing is worst on turning and at doorways and obstacles — each episode is a fall in the making.
Postural instability — two or more corrected steps backward on the pull test, or falling late Expected
Why: Loss of postural reflexes is a late motor sign (contrast: early in progressive supranuclear palsy) and responds poorly to dopaminergic drugs — safety measures, not more levodopa, are the treatment. About 60% of PD patients fall.
Orthostatic hypotension — systolic drop ≥ 20 mmHg or diastolic ≥ 10 within 3 minutes of standing Hold & notify
Why: Both a disease feature (sympathetic autonomic failure) and an effect of levodopa, dopamine agonists, and MAO-B inhibitors. A symptomatic drop is a hold-and-notify finding: the dopaminergic dose may need review, and the patient does not walk unassisted.
Constipation, urinary difficulties (retention, incontinence, nocturia), erectile dysfunction, sweating Expected
Why: Autonomic pathology — Braak stage 1 begins in the gut’s myenteric plexus, which is why constipation often precedes motor symptoms by years. Amantadine and anticholinergics add urinary retention and constipation on top.
Dysphagia and drooling — cough or wet voice on swallowing, pocketing food, weight loss late Hold & notify
Why: Basal-ganglia and frontal dopaminergic impairment weakens the swallow and reduces the automatic swallowing of saliva, so food, saliva, and gastric contents reach the airway. Affects at least 40% of late-stage patients; any cough, fever, or dyspnea after meals is reported and oral intake is paused pending a swallow evaluation.
REM sleep behavior disorder — punching, kicking, shouting while dreaming Expected
Why: Brainstem pathology removes the normal REM atonia, so dreams are acted out — with injuries to the patient or bed partner. Present in 30–50% of PD and often precedes motor disease by years; the response is bedroom safety, not restraint.
Depression, anxiety, apathy; cognitive decline progressing to dementia Expected
Why: Mood circuits lose dopaminergic and noradrenergic input early; cortical Lewy pathology arrives late. Depression affects about 47% after 3 years, cognitive decline develops in about 10% of patients per year, and 60–83% eventually develop Parkinson disease dementia. Screen for both — worse depression and cognition independently predict death.
Visual hallucinations, delusions, confusion — or new urges to gamble, shop, eat, or seek sex Hold & notify
Why: Psychosis is a feature of the disease and of every antiparkinson drug class; impulse-control disorders are a dopamine-agonist hazard that can appear on any dopaminergic therapy at any stage. Report immediately — the fix is a specialist-led dose review, never a routine antipsychotic, which would worsen the motor disease.
Wearing-off and dyskinesia — symptoms returning before the next dose; involuntary writhing of mouth, face, neck, and limbs late Hold & notify
Why: The shrinking dopamine reservoir makes the brain dependent on the plasma levodopa level (≈ 3–4 hours per dose). Document exactly when in the dosing cycle it happens — the pattern is what the specialist adjusts against. Patients must not self-adjust.
Fever + rigidity + confusion + autonomic instability within 1–3 days of missed, reduced, or malabsorbed doses (or a D2-blocking drug) Report immediately
Why: Sudden loss of dopaminergic tone precipitates parkinsonism-hyperpyrexia syndrome, a neuroleptic-malignant-like state with tachycardia, labile BP, diaphoresis, a profound CK rise, and leukocytosis. This is a rapid-response emergency: the dopaminergic drug goes back in, cooling and fluids start, and the patient goes to the ICU.

Diagnostics

Test In this disorder Normal
Clinical examination — MDS 2015 diagnostic criteria No lab or imaging study confirms PD — the diagnosis is clinical. Postural instability is not part of the MDS definition of parkinsonism. Supportive criteria: clear dopaminergic response, levodopa-induced dyskinesia, documented rest tremor, olfactory loss. Absolute exclusions include dopamine-antagonist exposure and normal presynaptic dopaminergic imaging. Red flags for atypical disease: recurrent falls (> 1/yr) within 3 years, early severe dysphagia, symmetric onset, wheelchair within 5 years. Observing the course for more than 5 years raises diagnostic accuracy from 53% to over 85% Parkinsonism = bradykinesia plus at least one of rest tremor or rigidity; then "clinically established" (no absolute exclusions, ≥ 2 supportive criteria, no red flags) or "clinically probable" (red flags allowed if counterbalanced 1:1 by supportive criteria) MDS 2015 criteria (as reported by Munhoz 2024 and the DGN 2023 guideline) —
Response to levodopa Acute levodopa and apomorphine tests "should not be performed routinely" to diagnose PD, although a marked acute response (UPDRS III > 30%) counts as a supportive criterion; accuracy improves with long-term follow-up by an expert A sustained, dramatic improvement (> 70%) over months of therapy is a supportive criterion; no response despite moderate severity is an absolute exclusion DGN 2023 guideline (Hopfner et al., J Neurol 2024) —
DaTscan (¹²³I-FP-CIT SPECT) Not a routine test — "its routine use is discouraged" — but it "may be performed early in the disease course to detect nigrostriatal deficits in cases where the diagnosis of Parkinson or tremor syndromes is unclear." Its nursing value is the drug-induced contrast — a normal scan in a rigid patient points back to the MAR Reduced striatal dopamine-transporter uptake in PD; symmetric, normal uptake in drug-induced parkinsonism and essential tremor DGN 2023 guideline; StatPearls Symmetric striatal uptake
MRI brain MRI "can exclude other causes of parkinsonism, such as tumors, NPH, or cerebrovascular accidents," and the DGN recommends cranial MRI early "to aid in the differential diagnosis of Parkinson syndromes" — it does not confirm PD itself Normal in PD — used to exclude other parkinsonian syndromes (normal-pressure hydrocephalus, stroke, mass) DGN 2023 guideline; StatPearls —
Hoehn & Yahr stage Stage 3 is the fall-risk hinge — postural reflexes fail. Severe non-motor symptoms are about 6× more likely at stage 3 and about 28× at stages 4–5 than at stages 1–2. The MDS-UPDRS quantifies mentation, mood, ADLs, tremor, motor exam, and complications for longitudinal tracking 1 unilateral, minimal disability · 2 bilateral or midline, balance intact · 3 bilateral with impaired postural reflexes, still independent · 4 severely disabling, still walks/stands unassisted · 5 wheelchair- or bed-bound unless aided —
Orthostatic vital signs Measure BP and HR supine and after 3 minutes standing — at admission, after any dopaminergic dose change, and before first ambulation. When positive, review the medication list — antihypertensives, antidepressants, and antiparkinsonian agents are listed causes, and the first non-drug step is to "Discontinue exacerbating medications" Systolic fall ≥ 20 mmHg or diastolic ≥ 10 mmHg within 3 minutes of standing (≥ 30 systolic if supine hypertension coexists) StatPearls: Autonomic Dysfunction Drop < 20/10 mmHg on standing
Labs — CK and WBC when withdrawal syndrome is suspected; monitoring on levodopa On levodopa, expect periodic BUN/creatinine, hepatic function, and vitamin B12 / methylmalonic acid (levodopa-associated neuropathy). In a patient who is falling, B12, thyroid function, and vitamin D are part of the work-up No lab diagnoses PD. In parkinsonism-hyperpyrexia syndrome: CK markedly elevated ("can be profound") and WBC 10,000–40,000/mm³ with a left shift —
Swallow evaluation Videofluoroscopic swallow study or fiberoptic endoscopic evaluation (VFSS/FEES) is the gold standard. Request the speech-language evaluation before oral intake whenever dysphagia is suspected; a gastrostomy may be indicated when conservative measures fail Bedside screen may show cough, wet voice, or delayed swallow — but the bedside exam misses more than 50% of significant aspiration —

Complications

Warning: Parkinsonism-hyperpyrexia syndrome — the withdrawal emergency Report immediately
Fever, rigidity, altered mental status, and autonomic instability (tachycardia, labile BP, diaphoresis) 1–3 days after antiparkinson drugs are stopped, cut, or malabsorbed — or after a dopamine-blocking drug.
A neuroleptic-malignant-like syndrome from abrupt loss of dopaminergic tone; levodopa and amantadine are the named triggers. CK "can be profound" and WBC runs 10,000–40,000. The treatment is the opposite of the reflex: restart the dopaminergic drug, cool aggressively, correct volume, ICU support, ± bromocriptine or dantrolene. Never stop these drugs abruptly — "stopping it suddenly can have potentially serious side effects." Mortality is now below 10% — with recognition.
Warning: Aspiration pneumonia — the leading cause of death Hold & notify
Cough, fever, or shortness of breath after meals; or the insidious version — fever and purulent sputum with no witnessed choking. PD carries more than 3 times the aspiration-pneumonia risk of controls.
Aspiration pneumonia is the most common cause of death in PD worldwide — 34% of late-stage deaths, with pneumonia and respiratory causes together at 55%. Hospital mortality with an aspiration pneumonia is about 10%, and after a first episode mortality climbs from 23.9% at one month to 65.2% at one year. Every off state deepens dysphagia, which is why on-time dosing is aspiration prevention. Report post-meal cough, fever, or dyspnea; hold oral intake and request the swallow evaluation.
Warning: Falls and fractures Hold & notify
About 60% of PD patients fall because of postural instability, and falls account for about 75% of hospitalizations in this population. Freezing at turns and doorways and orthostatic hypotension are the usual triggers.
Postural instability responds poorly to dopaminergic therapy, so the defense is environmental and rehabilitative: PD-specific physiotherapy with balance training and external cueing, safety handles and bars, assistive devices, orthostatic precautions, and a medication review for anything that causes dizziness, confusion, or slowing. Levodopa itself adds hip-fracture risk (homocysteine). Any fall — especially with a head strike in an older adult — is reported and assessed.
Caution: Motor complications — wearing-off, off periods, dyskinesia Hold & notify
Present in about 50% of patients after 5–10 years of levodopa: symptoms return before the next dose, "on" time shortens, and involuntary movements appear at peak effect.
The shrinking neuronal reservoir makes response track the plasma level of a drug that lasts 3–4 hours. Management is specialist-led — adjunct dopamine agonists, MAO-B or COMT inhibitors, amantadine, which "can also help reduce involuntary movements caused by other PD medicines," and in advanced disease deep brain stimulation or continuous levodopa/apomorphine infusion. The nurse’s job is the timing diary: when in the cycle does the patient go off, and when do the movements appear? Anticholinergics are used sparingly — they "can lead to adverse effects such as confusion and hallucinations."
Caution: Dementia, psychosis, and impulse-control disorders Hold & notify
Cognitive decline develops in about 10% of patients per year and 60–83% progress to Parkinson disease dementia; hallucinations and delusions arise from disease and drugs; dopamine agonists add gambling, shopping, hypersexuality, and binge eating.
The 12-month rule: PD established at least 12 months before cognitive impairment is Parkinson disease dementia; a shorter interval is dementia with Lewy bodies. For psychosis, the specialist reviews the antiparkinson drugs first, because they can cause hallucinations; when an antipsychotic is needed, "risperidone, ziprasidone, and olanzapine are more likely to cause drug-induced parkinsonism compared to quetiapine and clozapine," and "Psychotic symptoms are managed with antipsychotics and pimavanserin." Impulse-control disorders: the drugs "can cause strong urges to gamble, shop, have sex, or engage in other behaviors that are hard to control," so ask the patient and family about them and route any report to the specialist; "Impulse behaviors are managed by cognitive behavior therapy."

Medications for this condition

Why each class is prescribed here — every card links to its full pharmacology page.

Antiparkinson Agents First-line
Nervous · levodopa/carbidopa

The disorder is dopamine deficiency, so the drugs replace, mimic, or preserve dopamine. Levodopa/carbidopa is "the most effective treatment for the motor symptoms of PD"; dopamine agonists are "common treatments in early-stage PD or in combination with carbidopa-levodopa," and MAO-B inhibitors "slow the breakdown of dopamine in the brain." Carbidopa blocks peripheral conversion so more levodopa reaches the brain and less causes nausea. The nursing rules follow from the physiology: give it on the patient’s own schedule, 1 hour before or 2 hours after a protein meal (amino acids compete for the transporter), and never stop it abruptly — parkinsonism-hyperpyrexia syndrome is the price. Dopamine agonists bring impulse-control disorders and sudden-onset sleep, so patients are taught about both and should "refrain from driving if symptoms worsen"; MAO-B inhibitors bring serotonin-syndrome risk with SSRIs, tramadol, meperidine, and dextromethorphan; amantadine brings livedo reticularis and confusion in older adults; all of them can cause orthostatic hypotension and hallucinations.
Anticholinergics (Atropine)
Autonomic · atropine

The other side of the imbalance: with dopamine gone, striatal acetylcholine is relatively unopposed, and benztropine or trihexyphenidyl restore the balance by blocking muscarinic receptors. Their niche is tremor — benztropine is an adjunct for all forms of parkinsonism and is particularly useful for tremor, and they (with amantadine) treat drug-induced parkinsonism once the offending drug is stopped. The limits matter more than the indication: they "can lead to adverse effects such as confusion and hallucinations," and both agents are Beers-criteria potentially inappropriate in older adults (confusion, hallucinations, delirium, falls, urinary retention). Teach heat intolerance — they block sweating — and, like the dopaminergic drugs, they are not stopped abruptly.

Beyond medications

  • Physiotherapy — physical, occupational, and speech therapies help "with walking and speech, tremors and rigidity," and belong in the "multidisciplinary approach early in the illness." Balance exercises improve postural stability and reduce falls; gait training uses external cues (lines on the floor, rhythmic auditory cues), treadmill work, and home exercise; dance and martial arts have been studied as physiotherapy interventions.
  • Occupational therapy — for difficulties with activities of daily living — adaptive equipment, home modification, and techniques that preserve independence and reduce fear of falling.
  • Speech and language therapy — for soft speech and swallowing problems, including swallow-safety strategies and "Voice exercises to improve speech and swallowing"; "Regular follow-ups with a speech therapist are essential to address any speech-related issues that may arise."
  • Deep brain stimulation — a neurosurgeon places "a thin wire that carries electrical signals into the part of the brain that controls movements"; it is "usually considered for people with PD after medicines stop working well or cause difficult side effects." A battery pack sits "in the chest area under a person’s collarbone"; DBS "doesn’t cure the disease," does not improve speech problems, freezing, balance, mood, or dementia, and most patients continue medication at reduced doses.
  • Exercise and lifestyle — a balanced diet, regular physical activity, and adequate sleep are linked to better outcomes and lower mortality; the DGN suggests aerobic exercise 2–3×/week for 45–60 minutes in patients with mild cognitive impairment. Stay active and manage stress, which makes tremor more obvious.
  • Multidisciplinary team from diagnosis — neurology, PT/OT/SLT, nursing (education, side-effect monitoring, adherence), pharmacy (interactions, polypharmacy), dietitian, social work and mental health for caregiver support, disability and financial planning, and end-of-life or hospice information offered in time. Coordinated care reduces hospitalizations, medication errors, and caregiver strain. Advanced options include levodopa–carbidopa intestinal gel and continuous subcutaneous apomorphine or levodopa infusion.

Nursing considerations

The RN-specific layer — each action paired with the reason it matters.

Assessment & monitoring
On admission, record the patient’s exact home antiparkinson schedule (drug, dose, clock times) and compare it line-by-line with the hospital MAR; flag any dose mapped to a default "TID" or "with meals" slot.
Why: Levodopa lasts only about 3 to 4 hours, and as neurons are lost the "on" time shortens — so the home schedule is the one the specialist has already titrated, and any change goes through the prescriber. Without a dopamine reservoir, a two-hour shift is an off state.
Screen every MAR and every new PRN order for dopamine D2 blockers — metoclopramide, prochlorperazine, droperidol, haloperidol, and most antipsychotics — and question the order before giving it.
Why: D2 antagonists reproduce parkinsonism, blunt levodopa’s effect, and can precipitate abrupt motor worsening or the hyperpyrexia syndrome; high-potency antipsychotics such as haloperidol "are frequently associated with drug-induced parkinsonism," and patients taking D2 antagonists "may see a reduction in the effects of levodopa."
Assess motor status against the dosing cycle each shift: time of last dose, rigidity, ability to rise and walk, speech, swallow, and any dyskinesia — and document when in the cycle the patient is off.
Why: Wearing-off and dyskinesia track the 3–4-hour plasma curve of levodopa; the timing pattern is what the specialist adjusts against, and an unexplained off state is the first cue of a missed or blocked dose.
Measure orthostatic vital signs (supine, then 3 minutes standing) on admission, after any dopaminergic change, and before first ambulation; hold assisted ambulation and notify for a symptomatic drop ≥ 20/10 mmHg.
Why: Orthostatic hypotension is both autonomic disease and a drug effect of levodopa, agonists, and MAO-B inhibitors — and a fall in a patient with poor postural reflexes is the most common reason this population is hospitalized.
Watch for the withdrawal-syndrome tetrad — fever, worsening rigidity, confusion, and autonomic instability — in any patient who has been NPO, vomiting, or dose-reduced in the past 1–3 days; obtain CK and WBC and call a rapid response.
Why: Parkinsonism-hyperpyrexia syndrome is neuroleptic-malignant-like and treated by restarting the dopaminergic drug with cooling and ICU support; it is easily mistaken for sepsis or "just an off period."
Ask the patient and the carer directly at each review about hallucinations, confusion, daytime sleep attacks, and new urges — gambling, shopping, hypersexuality, binge eating — and screen for depression and cognitive change.
Why: Hallucinations and "strong urges to gamble, shop, have sex" are drug effects the specialist can adjust, but only if they are reported; depression (about 47%) and cognition independently predict mortality.
Interventions & safety — the off-state, aspiration, and fall bundle
Give antiparkinson drugs on time, every time — never hold a dose for NPO status, a procedure, or vomiting without a specialist- or pharmacist-directed plan (orally disintegrating or inhaled levodopa, subcutaneous apomorphine or levodopa infusion exist for exactly this purpose).
Why: "Abrupt withdrawal or dose reduction of levodopa is associated with an increased risk of neuroleptic malignant syndrome," and a dose that is withheld, vomited, or not absorbed is a dose reduction. No listed source gives a fixed NPO recipe — the rule is to obtain a plan before any interruption.
Aspiration precautions at every meal and medication pass: fully upright with the neck flexed, no talking while eating, and thickened liquids or texture-modified food as prescribed by the speech-language pathologist.
Why: Basal-ganglia dysphagia lets food and saliva reach the airway, and aspiration pneumonia is the leading cause of death in PD; the bedside swallow screen misses more than half of significant aspiration, so the precautions run whenever dysphagia is suspected, not only after it is proven.
Schedule meals and medication together sensibly: levodopa 1 hour before or 2 hours after a protein-heavy meal; if nausea is the problem, a small non-protein snack with the dose is acceptable — and treat nausea with an antiemetic that does not block D2.
Why: Dietary amino acids compete with levodopa for the same transporters, and high-fat meals delay absorption about 2 hours — a protein tray at the same time as the dose is a delayed or failed "on." Metoclopramide and prochlorperazine would trade nausea for an off state.
Fall bundle: bed low, call light and walker within reach, non-slip footwear, clear turning space at the bedside and doorways, assisted ambulation during off periods, and a cue ("step over the line," a counted rhythm) when the patient freezes.
Why: Freezing is worst on turning and at doorways; postural reflexes do not respond to levodopa, so environment and cueing are the treatment. About 60% of patients fall, and a hip fracture on top of PD is a step toward dependence.
Consistent oral hygiene before and after meals, minimal sedatives, head of bed elevated, and a speech-language swallow evaluation before oral intake in any patient with a wet voice, post-meal cough, or an off state.
Why: Oral care is associated with reduced hospital-acquired pneumonia; sedatives blunt the cough that protects the airway; and VFSS or FEES, not the bedside screen, is the gold standard for detecting silent aspiration.
Turn and inspect skin every 2 hours in the immobile patient, keep a bowel regimen running (polyethylene glycol is the named option), push fluids as allowed, and mobilize during "on" periods.
Why: Immobility in an off state threatens the skin; constipation is autonomic disease that ileus can turn into a levodopa-absorption failure; and 1.5–3 L/day of fluid (if not contraindicated) supports blood pressure against orthostasis.
Patient & family teaching
Take every dose at the same times every day, exactly as prescribed — "do not take more or less or more often" — and never stop suddenly. Bring the written home schedule to every hospital admission.
Why: Adherence is what keeps "on" time predictable, and abrupt cessation "could develop a serious syndrome that causes fever, rigid muscles, unusual body movements, and confusion."
Take levodopa 1 hour before or 2 hours after meals containing protein such as meat, poultry, and dairy; discuss protein timing with the prescriber rather than cutting protein out.
Why: Amino acids compete with levodopa for absorption, so a dose taken with a steak dinner may never switch the patient on — but malnutrition is its own PD complication.
Report immediately: seeing or hearing things that are not there, severe confusion, behavior changes, new urges to gamble, shop, eat, or seek sex, uncontrolled movements of the mouth, face, or limbs, and symptoms returning before the next dose.
Why: Psychosis, impulse-control disorders, dyskinesia, and wearing-off are all managed by specialist dose adjustment; patients who hide urges or self-adjust doses lose the chance for an early fix.
Sleep and driving: sudden-onset sleep can occur with levodopa and dopamine agonists — anyone with daytime sleepiness or sleep attacks must not drive; make the bedroom safe for REM sleep behavior disorder (bed low, floor padded, sharp objects and firearms secured, bed-partner safety).
Why: "Suddenly falling asleep" is a listed side effect of levodopa and the dopamine agonists; its "onset is rapid and without warning, and thus, precaution is needed when operating motor vehicles." Dream enactment injures patients and partners.
Orthostasis and heat: rise slowly in stages, use compression stockings, keep fluids and salt up unless restricted, avoid hot environments — especially on anticholinergics, which stop sweating — and report dizziness on standing.
Why: Sympathetic failure plus dopaminergic drugs drop the standing BP; anticholinergic anhidrosis removes the body’s cooling and can cause hyperthermia.
Home fall-proofing and swallow safety: "handles and bars for safety," tripping hazards removed, strength and balance exercise; upright meals with small bites, and a call to the provider for coughing, fever, or shortness of breath after eating, or weight loss.
Why: Falls account for three-quarters of hospitalizations in PD, and post-meal cough or fever is how aspiration pneumonia — the leading cause of death — announces itself; both are preventable with routines the family controls.

How a real nurse thinks

The clinical-judgment loop, worked for a typical presentation — reasoning, not reference.

  1. 1
    Recognize cues

    The cues that matter: a patient who walks with a cane at home is now rigid, unable to rise, hypophonic, drooling, and coughing on thin liquids — an acute functional collapse. Behind it sits the MAR: the 0600 dose was never given, the 1000 dose became a 0900 dose served with a high-protein breakfast, and the next is not due until 1300. Add a positive orthostatic drop, a wet voice after juice, and a D2-blocking antiemetic sitting on the PRN list. The noise: the low-grade temperature and WBC 13.2 are explained by the UTI he was admitted for — but they also mean fever will be easy to misattribute later.

  2. 2
    Analyze cues

    This is an off state from missed and malabsorbed dopaminergic doses, not disease progression and not "how PD patients look." After nine years his neuronal reservoir is small, so his motor state tracks the plasma level of a drug that lasts 3–4 hours — a skipped dose and a dose competing with a protein tray produced exactly the akinesia and rigidity that a missed dose predicts. The dysphagia is the same physiology applied to the swallow: an off-state pharynx cannot clear thin liquids, and a wet voice after juice is aspiration until proven otherwise. The trap is to read the rigidity and soft voice as baseline PD and to reach for the PRN metoclopramide when he complains of nausea — a D2 blocker that would deepen the off state.

  3. 3
    Prioritize

    The dangerous outcomes, in order: aspiration (the leading cause of death in PD, and he has already coughed on thin liquids), falls (rigid, orthostatic, and two-person assist), and — if the dosing gap continues into tomorrow — parkinsonism-hyperpyrexia syndrome, whose fever and confusion would hide behind his infection. So priority one is airway protection: nothing by mouth except with precautions until a swallow evaluation, and no thin liquids. Priority two is restoring dopamine on his schedule, which requires the prescriber. The nausea order can wait for a safe alternative; the UTI antibiotics are already running.

  4. 4
    Generate solutions

    Hold thin liquids and meal trays, keep him upright at 90 degrees, and request an SLP swallow evaluation before further oral intake. Contact the prescriber and pharmacist to re-time carbidopa/levodopa to his home schedule (0600/1000/1400/1800/2200) and to give a dose now rather than waiting for 1300 — it has been over five hours of effective dopamine gap. Ask that meals be separated from doses (1 hour before or 2 hours after protein) and that the metoclopramide PRN be replaced with a non-D2-blocking antiemetic. Bed low, call light in reach, two-person assist for any transfer, no unassisted ambulation while orthostatic. If he cannot swallow tablets safely, the plan must include an alternative route (orally disintegrating levodopa, or a specialist-directed option), not a held dose.

  5. 5
    Take action

    Act, then call: patient upright, thin liquids stopped, SLP paged, fall bundle in place — none of that needs an order. Then the SBAR: "74-year-old with 9 years of PD admitted for UTI. Home carbidopa/levodopa is five times daily at 0600, 1000, 1400, 1800, 2200; the MAR mapped it to TID with meals, so he missed his 0600 dose and got the 1000 dose at 0900 with a protein breakfast. He is now in an off state — rigid, two-person assist, hypophonic, drooling, coughed on juice with a wet voice, orthostatic 124/76 to 102/64. Requesting a dose now and re-timing to his home schedule with doses separated from protein meals, SLP swallow evaluation, and replacement of the PRN metoclopramide, which is a dopamine blocker." Document the pill times and the off-state findings in the same note so the pattern is visible. The trap to avoid: charting "rigidity, baseline for PD" and giving the PRN metoclopramide for his nausea.

  6. 6
    Evaluate

    Success over the next hours: a dose given and the MAR corrected to his home times; within an hour or two of the dose, rigidity easing, voice returning, able to stand with one assist; SLP evaluation done with a texture plan; no D2 blockers on the MAR; orthostatic drop rechecked before he walks. Re-escalation triggers, memorized in advance: any cough, fever, or dyspnea after intake (aspiration), and rising temperature with worsening rigidity, confusion, tachycardia, or labile BP over the next 1–3 days — in this patient that is parkinsonism-hyperpyrexia syndrome until proven otherwise, not "the UTI," and it is a rapid-response call with CK and WBC drawn and the dopaminergic drug given, not held.

Scenario — you’re the nurse

Work each question before revealing the answer. Rationales explain the wrong options too.

Medical unit · 1100, hospital day 2

A 74-year-old man with a 9-year history of Parkinson’s disease, admitted overnight for a urinary tract infection with dehydration. Home regimen per his wife: carbidopa/levodopa 25/100 at 0600, 1000, 1400, 1800, and 2200, plus pramipexole at bedtime. At home he walks with a cane and eats a regular diet. The admitting order set mapped carbidopa/levodopa to the hospital’s standard "TID with meals" times (0900, 1300, 1800); the 0900 dose was charted as given with the breakfast tray. The covering provider also ordered metoclopramide 10 mg IV PRN for nausea.

1100 vitals — HR 96 · BP 124/76 supine, 102/64 after 3 min standing · RR 20 · SpO₂ 95% on room air · T 37.4 °C
Assessment — marked cogwheel rigidity both arms · unable to rise from the chair without two-person assist · voice barely audible · masked face · drooling · coughed twice while sipping juice at breakfast; voice sounds wet afterward
Wife at bedside — "At home he’s up and walking by seven. He hasn’t been this stiff in years. He didn’t get his six o’clock pill and the one at nine came with his eggs and sausage."
MAR — carbidopa/levodopa 25/100 0900 ✓ (given with breakfast) · next due 1300 · pramipexole 2200 · metoclopramide 10 mg IV PRN nausea (not yet given) · ceftriaxone IV
Labs — WBC 13.2 · creatinine 1.3 (baseline 0.9) · CK not ordered · urinalysis positive
Q1 Select all that apply
Which findings require follow-up? Select all that apply.
  1. A. Carbidopa/levodopa charted as given at 0900 with the breakfast tray instead of at 1000 on an empty stomach
  2. B. Coughing on thin liquids with a wet-sounding voice afterward
  3. C. Blood pressure 124/76 supine falling to 102/64 after 3 minutes standing
  4. D. Metoclopramide IV PRN on the medication record
  5. E. Temperature 37.4 °C with a known urinary tract infection
Reveal answer & rationale
Answer: A, B, C, D
A dose shifted an hour early and given with a protein-rich meal (A) is a malabsorbed dose — amino acids compete with levodopa for absorption — and the MAR must be re-timed to the home schedule. Cough and a wet voice on thin liquids (B) are aspiration cues in a disorder where aspiration pneumonia is the leading cause of death; oral intake pauses pending a swallow evaluation. A systolic drop of 22 mmHg on standing (C) meets the orthostatic threshold (≥ 20/10) and is a hold-and-notify fall risk. Metoclopramide (D) is a dopamine D2 antagonist that worsens parkinsonism and blunts levodopa; the order is questioned before it is ever given. A temperature of 37.4 °C (E) in a patient already being treated for a UTI is expected and, on its own, not a follow-up item — though the nurse notes that infection will camouflage a later withdrawal fever.
Q2 Multiple choice
The patient reports nausea and asks for something to settle his stomach. Metoclopramide 10 mg IV is ordered PRN. The nurse’s best action is to:
  1. A. Administer the metoclopramide — nausea is a common levodopa side effect and this treats it
  2. B. Hold the metoclopramide, contact the prescriber, and request a non-dopamine-blocking antiemetic
  3. C. Give half the ordered dose to minimize side effects
  4. D. Withhold the 1300 carbidopa/levodopa dose until the nausea resolves
Reveal answer & rationale
Answer: B
Metoclopramide blocks striatal D2 receptors: it reproduces parkinsonism, reduces levodopa’s effectiveness, and can precipitate abrupt motor worsening — in a patient already in an off state it is the wrong drug at the worst time, so the nurse holds it and asks for an alternative (B). Giving it (A) trades nausea for deeper akinesia; a half dose (C) is still a D2 blocker and is not the nurse’s dose to choose. Withholding levodopa (D) is the dose reduction that risks the withdrawal syndrome — antiparkinson drugs are never stopped suddenly; nausea from levodopa is managed with carbidopa, dose timing, or a small non-protein snack, not by skipping the drug.
Q3 Put in order
Put the nurse’s first four actions in priority order:
  1. A. Notify the prescriber and pharmacist to re-time carbidopa/levodopa to the home schedule and give a dose now
  2. B. Sit the patient upright, stop thin liquids and trays, and request a speech-language swallow evaluation
  3. C. Document the home schedule, the MAR discrepancy, and the off-state findings
  4. D. Lower the bed, place the call light and walker within reach, and set two-person assist for transfers
Reveal answer & rationale
Correct order: B → D → A → C
Airway first: he has already coughed on thin liquids with a wet voice, and aspiration pneumonia is what kills PD patients, so intake stops and he sits upright before anything else (B). Falls are the next injury waiting — rigid, orthostatic, two-person assist — and the fall bundle needs no order (D). Then the call that fixes the cause: re-timing the MAR and giving a dose now (A), which restores the swallow and the gait over the next hour or two. Documentation (C) matters — the timing pattern is what the specialist adjusts against — but never precedes protecting the patient. Calling first (A) leaves a patient sipping juice with an unprotected airway while the nurse is on the phone.
Q4 Multiple choice
Hospital day 3, 0500: the patient is now febrile at 39.2 °C, more rigid than at any point yesterday, confused, diaphoretic, HR 124, BP swinging between 168/98 and 96/58. The night nurse notes the 2200 and 0600 doses were held "because he was too sleepy to swallow safely." These findings most likely indicate:
  1. A. Sepsis from the urinary tract infection — increase antibiotics and continue holding the oral doses
  2. B. Parkinsonism-hyperpyrexia syndrome from dopaminergic withdrawal — a rapid-response emergency
  3. C. Expected overnight wearing-off that will resolve with the 0900 dose
  4. D. Serotonin syndrome from the antibiotic
Reveal answer & rationale
Answer: B
Fever + rigidity + mental status change + autonomic instability within 1–3 days of held or malabsorbed dopaminergic doses is parkinsonism-hyperpyrexia syndrome, the neuroleptic-malignant-like emergency that "Abrupt withdrawal or dose reduction of levodopa" risks (B): call a rapid response, draw CK and WBC, start cooling and fluids, and get the dopaminergic drug back in — by an alternative route if he cannot swallow, never by continuing to hold. Sepsis (A) is the camouflage — the infection is real, but sepsis does not produce escalating rigidity, and "continue holding" is the action that would kill him. Wearing-off (C) is a predictable pre-dose slump, not fever and labile blood pressure. Serotonin syndrome (D) involves serotonergic drugs (SSRIs, tramadol, meperidine with an MAO-B inhibitor), none of which are in play.
Q5 Select all that apply
Before discharge, the patient’s wife asks what to watch for at home. Which statements show she understood the teaching? Select all that apply.
  1. A. "His pills go in at the same five times every day, and I bring the written schedule to any hospital."
  2. B. "If he runs out of levodopa on a weekend, we just wait until Monday — a couple of days off won’t hurt."
  3. C. "He takes his levodopa an hour before or two hours after a meal with meat or dairy."
  4. D. "If he starts coughing during meals or runs a fever after eating, I call the clinic."
  5. E. "If he suddenly starts gambling online or seeing people who aren’t there, I keep it private — that’s not a medical issue."
Reveal answer & rationale
Answer: A, C, D
Same-times-every-day dosing and carrying the schedule into every admission (A) is the hospital-safety lesson of this case. Separating levodopa from protein by 1 hour before or 2 hours after (C) protects absorption. Post-meal cough or fever (D) is how aspiration pneumonia — the leading cause of death in PD — announces itself, and it is reported. Waiting days without levodopa (B) is exactly the abrupt withdrawal that causes fever, rigidity, unusual movements, and confusion; and a lapse in supply is a same-day call. New gambling or hallucinations (E) are impulse-control disorder and psychosis — dopamine-agonist and disease effects that the team must hear about immediately so the specialist can adjust therapy; hiding them is the failure mode that routine questioning exists to prevent.

Common questions

What causes parkinson’s disease?
Common causes and risk factors include age — about 1% of people over 60 and 2–3% over 65; onset usually around 60, male sex (≈ 2:1), family history — ≈ 10% genetic; lrrk2 is the most common variant (40% of familial cases); also gba1, snca, vps35, prkn, pink1, dj1, onset before age 50, or two first-degree relatives (or one first-degree + one second-degree) with pd → genetic testing considered (dgn 2023), pesticide and herbicide exposure; living near industrial plants, and others.
What are the early signs of parkinson’s disease?
Early findings include Bradykinesia — slow initiation of movement with shrinking speed and amplitude on repetition, Resting tremor — 4–6 Hz, "pill-rolling," typically unilateral at onset, Rigidity — lead-pipe or cogwheel resistance to passive movement, often asymmetric.
Which findings should a nurse report immediately in parkinson’s disease?
Report immediately: Fever + rigidity + confusion + autonomic instability within 1–3 days of missed, reduced, or malabsorbed doses (or a D2-blocking drug), Parkinsonism-hyperpyrexia syndrome — the withdrawal emergency. These signal deterioration that needs rapid intervention.
Why do Parkinson’s medications have to be given exactly on time in the hospital?
Because in established PD the surviving nigral neurons no longer store enough dopamine to buffer a dose, so the patient’s mobility tracks the plasma level of levodopa — a drug that lasts only about 3 to 4 hours. A dose delayed an hour or two produces an off state: rigidity, inability to rise, a weak swallow, drooling, and fall risk. So hospitalized patients get their medicines at their home times, with changes made only through the prescriber, and the drugs are never stopped abruptly: "Abrupt withdrawal or dose reduction of levodopa is associated with an increased risk of neuroleptic malignant syndrome." The practical rules: record the home clock times on admission, never let the MAR default to "TID with meals," give levodopa 1 hour before or 2 hours after protein, and obtain a plan before any NPO period.
Which common hospital drugs make Parkinson’s disease worse?
Anything that blocks dopamine D2 receptors in the striatum: the antiemetics metoclopramide, prochlorperazine, and droperidol; typical antipsychotics such as haloperidol and fluphenazine; and several atypicals including risperidone, ziprasidone, and olanzapine (olanzapine is among the atypicals "more likely to cause drug-induced parkinsonism compared to quetiapine and clozapine"). These drugs reproduce parkinsonism, reduce levodopa’s effectiveness, and can precipitate abrupt motor worsening. When a PD patient hallucinates, the first step is a specialist review of the antiparkinson drugs, then quetiapine or clozapine — not a routine antipsychotic. When a PD patient is nauseated, ask for an antiemetic that does not block D2.
What is parkinsonism-hyperpyrexia syndrome and how is it treated?
It is the neuroleptic-malignant-like emergency that follows abrupt withdrawal, dose reduction, or sudden malabsorption of dopaminergic drugs (levodopa and amantadine are the named triggers) — or a dopamine-blocking drug. Over 1–3 days the patient develops fever, severe muscle rigidity, altered mental status, and autonomic instability (tachycardia, labile blood pressure, sweating); creatine kinase can rise enormously and the white count reaches 10,000–40,000 with a left shift. Treatment is to restart the dopaminergic drug (by an alternative route if the patient cannot swallow), cool aggressively, correct fluid volume, and provide ICU support, sometimes with bromocriptine or dantrolene. Mortality is now under 10%, but only when it is recognized — in hospital it hides behind infection, so any PD patient who has missed doses and develops fever with worsening rigidity is treated as this syndrome first.

Sources

Reviewed by Hae Suk Lee, RN

Educational summary for nursing students. Scenarios are fictional teaching cases. Always verify against current guidelines and your institution's protocols before acting in practice. Not medical advice.

Bookmark LearnDrugs.com?

Your saved pages are kept in this browser. Add LearnDrugs.com to your browser’s bookmarks to get back to them in one click.

Drag this link to your bookmarks bar: LearnDrugs.com

Or press Ctrl + D to bookmark the page you’re on.